-
1
-
-
84883802365
-
-
American Cancer Society. What are the key statistics about basal and squamous cell skin cancers?. Updated January 17, 2013. AccessedJune 17
-
American Cancer Society. What are the key statistics about basal and squamous cell skin cancers? http://www.cancer.org/cancer/skincancer-basalandsquamouscell/detailedgui de/skin-cancer-basal-and-squamous-cell-key-statistics. Updated January 17, 2013. AccessedJune 17, 2013.
-
(2013)
-
-
-
2
-
-
33646865910
-
High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease
-
Veness MJ, Palme CE, Morgan GJ. High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;106:2389-2396.
-
(2006)
Cancer
, vol.106
, pp. 2389-2396
-
-
Veness, M.J.1
Palme, C.E.2
Morgan, G.J.3
-
3
-
-
60449092062
-
Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior [published online ahead of print July 22, 2008]
-
McGuire JF, Ge NN, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior [published online ahead of print July 22, 2008]. Am J Otolaryngol. 2009;30:121-133.
-
(2009)
Am J Otolaryngol
, vol.30
, pp. 121-133
-
-
McGuire, J.F.1
Ge, N.N.2
Dyson, S.3
-
4
-
-
0024410723
-
Metastases from squamous cell carcinoma of the skin and lip. an analysis of twenty-seven cases
-
Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip. an analysis of twenty-seven cases. J Am Acad Dermatol. 1989;21(2, pt 1):241-248.
-
(1989)
J Am Acad Dermatol.
, vol.21
, Issue.2 PT 1
, pp. 241-248
-
-
Dinehart, S.M.1
Pollack, S.V.2
-
5
-
-
0026773479
-
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lipimplications for treatment modality selection
-
Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. implications for treatment modality selection. J Am Acad Dermatol. 1992;26:976-990.
-
(1992)
J Am Acad Dermatol.
, vol.26
, pp. 976-990
-
-
Rowe, D.E.1
Carroll, R.J.2
Day, C.L.Jr.3
-
6
-
-
0018412109
-
Tissue conservation in treatment of cutaneous neoplasms of the head and neck combined use of Mohs' chemosurgical and conventional surgical techniques
-
Levine H, Bailin P, Wood B, et al. Tissue conservation in treatment of cutaneous neoplasms of the head and neck. combined use of Mohs' chemosurgical and conventional surgical techniques. Arch Otolaryngol. 1979;105:140-144.
-
(1979)
Arch Otolaryngol.
, vol.105
, pp. 140-144
-
-
Levine, H.1
Bailin, P.2
Wood, B.3
-
7
-
-
11144335464
-
A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia
-
Nolan RC, Chan MT, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101-108.
-
(2005)
J Am Acad Dermatol
, vol.52
, pp. 101-108
-
-
Nolan, R.C.1
Chan, M.T.2
Heenan, P.J.3
-
8
-
-
18044372236
-
Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice
-
Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115:870-875.
-
(2005)
Laryngoscope
, vol.115
, pp. 870-875
-
-
Veness, M.J.1
Morgan, G.J.2
Palme, C.E.3
-
9
-
-
36849047227
-
Squamous cell carcinoma in children and young adults: a new wave of a very rare tumor?
-
Chow CW, Tabrizi SN, Tiedemann K, et al. Squamous cell carcinoma in children and young adults: a new wave of a very rare tumor?. J Pediatr Surg. 2007;42:2035-2039.
-
(2007)
J Pediatr Surg
, vol.42
, pp. 2035-2039
-
-
Chow, C.W.1
Tabrizi, S.N.2
Tiedemann, K.3
-
10
-
-
0041866528
-
Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK
-
Pearce MS, Parker L, Cotterill SJ, et al. Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK. Melanoma Res. 2003;13:421-426.
-
(2003)
Melanoma Res
, vol.13
, pp. 421-426
-
-
Pearce, M.S.1
Parker, L.2
Cotterill, S.J.3
-
11
-
-
67649410201
-
Cutaneous squamous cell carcinoma in a child [published online ahead of print April 15, 2009]
-
Kotwal A, Watt D. Cutaneous squamous cell carcinoma in a child [published online ahead of print April 15, 2009]. J Plast Reconstr Aesthet Surg. 2009;62:194-195.
-
(2009)
J Plast Reconstr Aesthet Surg
, vol.62
, pp. 194-195
-
-
Kotwal, A.1
Watt, D.2
-
12
-
-
23344447769
-
Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years
-
Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294:681-690.
-
(2005)
JAMA
, vol.294
, pp. 681-690
-
-
Christenson, L.J.1
Borrowman, T.A.2
Vachon, C.M.3
-
13
-
-
84883801219
-
-
Humira [package insert]. North Chicago, IL: AbbVie, Inc
-
Humira [package insert]. North Chicago, IL: AbbVie, Inc; 2013.
-
(2013)
-
-
-
14
-
-
36049048398
-
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation
-
McLeod C, Bagust A, Boland A, et al. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1-158, iii-iv.
-
(2007)
Health Technol Assess
, vol.11
, pp. 1-158
-
-
McLeod, C.1
Bagust, A.2
Boland, A.3
-
15
-
-
77953710657
-
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumor necrosis factor ainhibitors [published online ahead of print September 9, 2009]
-
Pedersen SJ, Sørensen IJ, Hermann KG, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumor necrosis factor ainhibitors [published online ahead of print September 9, 2009]. Ann Rheum Dis. 2010;69:1065-1071.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1065-1071
-
-
Pedersen, S.J.1
Srensen, I.J.2
Hermann, K.G.3
-
16
-
-
66149125235
-
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis [published online ahead of print February 27, 2009]
-
Rudwaleit M, Claudepierre P, Wordsworth P. Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis [published online ahead of print February 27, 2009]. J Rheumatol. 2009;36:801-808.
-
(2009)
J Rheumatol
, vol.36
, pp. 801-808
-
-
Rudwaleit, M.1
Claudepierre, P.2
Wordsworth, P.3
-
17
-
-
67449116868
-
ATLAS Study Group. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial [published online ahead of print August 13, 2008]
-
van der Heijde D, Schiff MH, Sieper J, et al; ATLAS Study Group. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial [published online ahead of print August 13, 2008]. Ann Rheum Dis. 2009;68:922-929.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 922-929
-
-
van der Heijde, D.1
Schiff, M.H.2
Sieper, J.3
-
18
-
-
2642620207
-
A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK
-
Lear JT, Tan BB, Smith AG, et al. A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. Int J Clin Pract. 1998;52:145-149.
-
(1998)
Int J Clin Pract
, vol.52
, pp. 145-149
-
-
Lear, J.T.1
Tan, B.B.2
Smith, A.G.3
-
19
-
-
33644840579
-
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study
-
Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer. 2006;94:743-751.
-
(2006)
Br J Cancer
, vol.94
, pp. 743-751
-
-
Zanetti, R.1
Rosso, S.2
Martinez, C.3
-
20
-
-
33846805780
-
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review
-
International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer.
-
International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer. 2007;120:1116-1122.
-
(2007)
Int J Cancer
, vol.120
, pp. 1116-1122
-
-
-
21
-
-
0037028735
-
Use of tanning devices and risk of basal cell and squamous cell skin cancers
-
Karagas MR, Stannard VA, Mott LA, et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94:224-226.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 224-226
-
-
Karagas, M.R.1
Stannard, V.A.2
Mott, L.A.3
-
22
-
-
33745012160
-
Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort
-
Lindelöf B, Jarnvik J, Ternesten-Bratel A, et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort. Acta Derm Venereol. 2006;86:219-222.
-
(2006)
Acta Derm Venereol
, vol.86
, pp. 219-222
-
-
Lindelöf, B.1
Jarnvik, J.2
Ternesten-Bratel, A.3
-
23
-
-
0036283502
-
Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus
-
Nguyen P, Vin-Christian K, Ming ME, et al. Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol. 2002;138:758-763.
-
(2002)
Arch Dermatol
, vol.138
, pp. 758-763
-
-
Nguyen, P.1
Vin-Christian, K.2
Ming, M.E.3
-
24
-
-
33845956092
-
An increase in basal cell carcinoma among the young: an epidemiological study in a middle-south Italian population
-
Delfino S, Innocenzi D, Di Lorenzo G, et al. An increase in basal cell carcinoma among the young: an epidemiological study in a middle-south Italian population. Anticancer Res. 2006;26:4979-4983.
-
(2006)
Anticancer Res
, vol.26
, pp. 4979-4983
-
-
Delfino, S.1
Innocenzi, D.2
Di Lorenzo, G.3
-
25
-
-
0026633652
-
Basal cell carcinoma in young adults
-
Cox NH. Basal cell carcinoma in young adults. Br J Dermatol. 1992;127:26-29.
-
(1992)
Br J Dermatol
, vol.127
, pp. 26-29
-
-
Cox, N.H.1
-
26
-
-
4644335843
-
Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973
-
de Vries E, Louwman M, Bastiaens M, et al. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol. 2004;123:634-638.
-
(2004)
J Invest Dermatol
, vol.123
, pp. 634-638
-
-
de Vries, E.1
Louwman, M.2
Bastiaens, M.3
-
27
-
-
35549007228
-
TNF-a inhibitor etanercept and hematologic malignancies: report of a case and review of the literature
-
Nair B, Raval G, Mehta P. TNF-a inhibitor etanercept and hematologic malignancies: report of a case and review of the literature. Am J Hematol. 2007;82:1022-1024.
-
(2007)
Am J Hematol
, vol.82
, pp. 1022-1024
-
-
Nair, B.1
Raval, G.2
Mehta, P.3
-
28
-
-
39749177707
-
Antitumor necrosis factor-a therapy and potential cancer inhibition
-
Williams GM. Antitumor necrosis factor-a therapy and potential cancer inhibition. Eur J Cancer Prev. 2008;17:169-177.
-
(2008)
Eur J Cancer Prev
, vol.17
, pp. 169-177
-
-
Williams, G.M.1
-
29
-
-
0035179804
-
Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor a receptor IgG1-Fc fusion complex therapy
-
Smith KJ, Skelton HG. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor a receptor IgG1-Fc fusion complex therapy. J Am Acad Dermatol. 2001;45:953-956.
-
(2001)
J Am Acad Dermatol
, vol.45
, pp. 953-956
-
-
Smith, K.J.1
Skelton, H.G.2
-
30
-
-
0032983865
-
Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis
-
Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis. Nat Med. 1999;5:828-831.
-
(1999)
Nat Med
, vol.5
, pp. 828-831
-
-
Moore, R.J.1
Owens, D.M.2
Stamp, G.3
-
31
-
-
27744527575
-
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
-
Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64:1421-1426.
-
(2005)
Ann Rheum Dis
, vol.64
, pp. 1421-1426
-
-
Askling, J.1
Fored, C.M.2
Brandt, L.3
-
32
-
-
34848893989
-
Biologic treatment of rheumatoid arthritis and the risk of malignancy: analysis from a large US observational study
-
Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analysis from a large US observational study. Arthritis Rheum. 2007;56:2886-2895.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 2886-2895
-
-
Wolfe, F.1
Michaud, K.2
-
33
-
-
27744499707
-
Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
-
Chakravarty EF, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol. 2005;32:2130-2135.
-
(2005)
J Rheumatol
, vol.32
, pp. 2130-2135
-
-
Chakravarty, E.F.1
Michaud, K.2
Wolfe, F.3
-
34
-
-
80455142808
-
Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
-
Amari W, Zeringue AL, McDonald JR, et al. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis. Rheumatology (Oxford). 2011;50:1431-1439.
-
(2011)
Rheumatology (Oxford)
, vol.50
, pp. 1431-1439
-
-
Amari, W.1
Zeringue, A.L.2
McDonald, J.R.3
-
35
-
-
78751685797
-
Cancer risk with tumor necrosis factor α (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
-
Askling J, Fahrbach K, Nordstrom B, et al. Cancer risk with tumor necrosis factor α (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf. 2011;20:119-130.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 119-130
-
-
Askling, J.1
Fahrbach, K.2
Nordstrom, B.3
-
36
-
-
84859448342
-
Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials
-
LE Blay P, Mouterde G, Barnetche T, et al. Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials. J Rheumatol. 2012;39:712-715.
-
(2012)
J Rheumatol
, vol.39
, pp. 712-715
-
-
Le Blay, P.1
Mouterde, G.2
Barnetche, T.3
-
37
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275-2285.
-
(2006)
JAMA
, vol.295
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
-
38
-
-
67549117204
-
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analysis of serious adverse events
-
Leombruno JP, Einarson TR, Keystone EC. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analysis of serious adverse events. Ann Rheum Dis. 2009;68:1136-1145.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1136-1145
-
-
Leombruno, J.P.1
Einarson, T.R.2
Keystone, E.C.3
-
39
-
-
67349084672
-
Treatments for psoriasis and the risk of malignancy [published correction in J Am Acad Dermatol 2009;61:1059]
-
Patel RV, Clark LN, Lebwohl M, et al. Treatments for psoriasis and the risk of malignancy [published correction in J Am Acad Dermatol. 2009;61:1059]. J Am Acad Dermatol. 2009;60:1001-1017.
-
(2009)
J Am Acad Dermatol
, vol.60
, pp. 1001-1017
-
-
Patel, R.V.1
Clark, L.N.2
Lebwohl, M.3
-
40
-
-
79956108951
-
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of controlled trials
-
Dommasch ED, Abuabara K, Shin DB, et al. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of controlled trials. J Am Acad Dermatol. 2011;64:1035-1050.
-
(2011)
J Am Acad Dermatol
, vol.64
, pp. 1035-1050
-
-
Dommasch, E.D.1
Abuabara, K.2
Shin, D.B.3
-
41
-
-
84883825729
-
The immunomodulatory/immunosuppressive classification sys-tem
-
Koo JYM, Lee CS, Lebwohl MG, et al, eds Moderate-to-Severe Psoriasis. 3rd ed. New York, NY: Taylor & Francis
-
Koo JYM, Behnam SM, Behnam SE, et al. The immunomodulatory/immunosuppressive classification sys-tem. In: Koo JYM, Lee CS, Lebwohl MG, et al, eds. Moderate-to-Severe Psoriasis. 3rd ed. New York, NY: Taylor & Francis; 2009:365-377.
-
, vol.2009
, pp. 365-377
-
-
Koo, J.Y.M.1
Behnam, S.M.2
Behnam, S.E.3
-
42
-
-
0037318161
-
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study
-
Paul CF, Ho VC, McGeown C, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol. 2003;120:211-216.
-
(2003)
J Invest Dermatol
, vol.120
, pp. 211-216
-
-
Paul, C.F.1
Ho, V.C.2
McGeown, C.3
-
43
-
-
34848924391
-
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation
-
Kako S, Izutsu K, Oshima K, et al. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2007;82:937-939.
-
(2007)
Am J Hematol
, vol.82
, pp. 937-939
-
-
Kako, S.1
Izutsu, K.2
Oshima, K.3
-
44
-
-
0024443735
-
Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A
-
Ulrich W, Chott A, Watschinger B, et al. Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A. Hum Pathol. 1989;20:1027-1030.
-
(1989)
Hum Pathol
, vol.20
, pp. 1027-1030
-
-
Ulrich, W.1
Chott, A.2
Watschinger, B.3
-
45
-
-
0026649105
-
Lymphoma in cyclosporine-treated renal transplant recipients
-
Chu SH, Lai MK, Huang CC, et al. Lymphoma in cyclosporine-treated renal transplant recipients. Transplant Proc. 1992;24:1594-1595.
-
(1992)
Transplant Proc
, vol.24
, pp. 1594-1595
-
-
Chu, S.H.1
Lai, M.K.2
Huang, C.C.3
|